platinum has been researched along with Thrombocytopenia in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (26.32) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 5 (26.32) | 2.80 |
| Authors | Studies |
|---|---|
| Abadie-Lacourtoisie, S; Blanc-Fournier, C; Brachet, PE; Briand, M; Clarisse, B; Fabbro, M; Floquet, A; Follana, P; Frenel, JS; Gavoille, C; Giffard, F; Gladieff, L; Joly, F; Just, PA; Kalbacher, E; Leary, A; Leconte, A; Lequesne, J; Lesoin, A; Medioni, J; Poulain, L; Weiswald, LB; You, B | 1 |
| Guo, Z; Jia, Y; Song, R; Wu, C; Zhang, R; Zhang, S; Zhang, X; Zhao, Y | 1 |
| Abe, M; Aida, T; Baba, T; Chiba, Y; Kagabu, M; Kaido, Y; Nagasawa, T; Shoji, T; Takahashi, F; Takatori, E | 1 |
| Cai, ZC; Chen, X; Deng, Y; Guo, X; Huang, HY; Huang, YY; Liang, CX; Lv, X; Qiang, MY; Zhan, ZJ; Zhang, LL; Zhou, JY | 1 |
| Doi, H; Ishigaki, H; Kijima, T; Kitajima, K; Koda, Y; Kuribayashi, K; Minami, T; Nakajima, Y; Nakamura, A; Takahashi, R; Yokoi, T | 1 |
| Dong, M; Gui, L; He, X; Hu, S; Jia, B; Liu, P; Qin, Y; Yang, J; Yang, S; Zhang, C; Zhou, S | 1 |
| Hamada, Y; Hayakawa, K; Kotani, A; Kusu, F; Naitoh, H; Niibe, Y; Takayanagi, R; Tsunoda, S; Unno, N; Yago, K; Yamada, Y | 1 |
| Li, LF; Li, W; Liu, XM; Qian, ZZ; Qiu, LH; Wang, HQ; Zhang, HL | 1 |
| Cao, DD; Chen, Y; Ge, W; Jie, FF; Wang, HM; Zheng, YF | 1 |
| Guan, ZZ; Guo, Y; Huang, H; Jiang, WQ; Li, S; Liao, H; Yang, XQ; Zhan, J; Zou, BY | 1 |
| Brunetti, C; Cassano, G; Colucci, G; Galetta, D; Gebbia, V; Germano, D; Giampaglia, M; Guida, M; Izzi, G; Lorusso, V; Nettis, G; Silvestris, N; Spada, M | 1 |
| Aisner, J; Egorin, MJ; Olman, EA; Van Echo, DA; Whitacre, MY | 1 |
| Adams, M; Fish, RG; Griffiths, H; James, K; Mason, M; Shelley, MD | 1 |
| Adelstein, D; Bauer, L; Budd, GT; Bukowski, RM; Ganapathi, R; Gibson, V; McLain, D; Murthy, S; Sergi, J; Weick, J | 1 |
| Fujiwara, K; Fujiwara, M; Ishikawa, H; Kohno, I; Suzuki, S; Tanaka, Y; Yamauchi, H | 1 |
| Chen, JT; Fujimoto, I; Hamada, T; Hasumi, K; Hirai, Y; Nakayama, K; Shimizu, Y; Teshima, H; Yamauchi, K; Yokosuka, K | 1 |
| Majima, H | 1 |
| Engelfriet, CP; van Boxtel, CJ; van der Weerdt, CM | 1 |
| Perlia, CP; Rossof, AH; Slayton, RE | 1 |
2 review(s) available for platinum and Thrombocytopenia
| Article | Year |
|---|---|
Comparison of Efficacy and Safety of Taxanes Plus Platinum and Fluorouracil Plus Platinum in the First-Line Treatment of Esophageal Cancer: A Systematic Review and Meta-Analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Esophageal Neoplasms; Fluorouracil; Humans; Leukopenia; Lung Neoplasms; Platinum; Taxoids; Thrombocytopenia | 2022 |
Endostar combined with chemotherapy versus chemotherapy alone for advanced NSCLCs: a meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Endostatins; Humans; Leukopenia; Lung Neoplasms; Nausea; Platinum; Randomized Controlled Trials as Topic; Recombinant Proteins; Thrombocytopenia; Treatment Outcome; Vomiting | 2011 |
5 trial(s) available for platinum and Thrombocytopenia
| Article | Year |
|---|---|
A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI - GINECO study.
Topics: Aniline Compounds; Carcinoma, Ovarian Epithelial; Female; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platinum; Prospective Studies; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Thrombocytopenia | 2022 |
Phase I clinical trial of the novel platin complex dicycloplatin: clinical and pharmacokinetic results.
Topics: Adult; Aged; Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; China; Cyclobutanes; Dicarboxylic Acids; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neoplasms; Neutropenia; Platinum; Thrombocytopenia; Vomiting | 2013 |
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial.
Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Platinum; Thrombocytopenia; Topotecan; Treatment Outcome | 2005 |
A dosing scheme for carboplatin in adult cancer patients based upon pre-infusion renal function and platelet count.
Topics: Adenocarcinoma; Aged; Carboplatin; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Humans; Kidney Function Tests; Male; Middle Aged; Monte Carlo Method; Ovarian Neoplasms; Platelet Count; Platinum; Risk Factors; Teratoma; Testicular Neoplasms; Thrombocytopenia | 1994 |
Phase I study of WR-2721 and carboplatin.
Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Platinum; Thrombocytopenia | 1993 |
12 other study(ies) available for platinum and Thrombocytopenia
| Article | Year |
|---|---|
Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study.
Topics: Adenosine Diphosphate Ribose; Bevacizumab; Carboplatin; Carcinoma, Ovarian Epithelial; Fallopian Tubes; Female; Humans; Neutropenia; Ovarian Neoplasms; Paclitaxel; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Retrospective Studies; Thrombocytopenia | 2023 |
Incidence, consequences, and predictors of serious chemotherapy-induced thrombocytopenia in nasopharyngeal carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Humans; Incidence; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Platinum; Prognosis; Retrospective Studies; Thrombocytopenia | 2023 |
Irinotecan and Gemcitabine as Second-Line Treatment in Patients with Malignant Pleural Mesothelioma following Platinum plus Pemetrexed Chemotherapy: A Retrospective Study.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Irinotecan; Japan; Kaplan-Meier Estimate; Leukopenia; Male; Mesothelioma, Malignant; Middle Aged; Neutropenia; Pemetrexed; Platinum; Progression-Free Survival; Retrospective Studies; Thrombocytopenia | 2021 |
[Efficacy and safety evaluation of gemcitabine combined with ifosfamide in patients with advanced nasopharyngeal carcinoma after failure of platinum-based chemotherapy].
Topics: Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Deoxycytidine; Disease-Free Survival; Gemcitabine; Humans; Ifosfamide; Induction Chemotherapy; Kaplan-Meier Estimate; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neutropenia; Platinum; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia; Treatment Failure | 2015 |
Initial analysis of relationship between plasma platinum concentration and hematological adverse reaction associated with weekly chemotherapy using nedaplatin in combination with radiotherapy for cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Leukopenia; Middle Aged; Organoplatinum Compounds; Pilot Projects; Platinum; Thrombocytopenia; Uterine Cervical Neoplasms | 2010 |
[Nimotuzumab in combination with chemotherapy in patients with advanced non-small cell lung cancer].
Topics: Adult; Aged; Agranulocytosis; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Exanthema; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Platinum; Remission Induction; Retrospective Studies; Thrombocytopenia; Vomiting | 2011 |
Phase I clinical and pharmacologic trial of carboplatin daily for 5 days.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Drug Evaluation; Female; Humans; Kinetics; Male; Middle Aged; Neoplasms; Organoplatinum Compounds; Platinum; Pleural Effusion; Thrombocytopenia | 1984 |
The platelet-sparing effect of paclitaxel is not related to changes in the pharmacokinetics of carboplatin.
Topics: Age Factors; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Body Surface Area; Carboplatin; Cyclophosphamide; Female; Humans; Injections, Intraperitoneal; Middle Aged; Ovarian Neoplasms; Paclitaxel; Platelet Count; Platinum; Prospective Studies; Thrombocytopenia | 2001 |
[CDDP-ACR treatment in patients with recurrent ovarian cancer with prior chemotherapy containing CDDP--a preliminary study of a 14-day continuous infusion of CDDP with ACR].
Topics: Abdominal Neoplasms; Aclarubicin; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystadenocarcinoma; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms; Platinum; Recurrence; Remission Induction; Thrombocytopenia | 1989 |
[Present status of cisplatin (CDDP) analogues in Japan].
Topics: Antineoplastic Agents; Carboplatin; Chemical Phenomena; Chemistry; Cisplatin; Female; Humans; Kidney; Leukopenia; Nervous System; Organoplatinum Compounds; Platinum; Protein Binding; Thrombocytopenia | 1989 |
Cell electrophoresis for the detection of platelet antibodies.
Topics: ABO Blood-Group System; Animals; Antibodies; Blood Cell Count; Blood Platelets; Buffers; Complement Fixation Tests; Complement System Proteins; Electrodes; Electrophoresis; Electrophoresis, Polyacrylamide Gel; Erythrocytes; Hemagglutination Tests; Humans; Hydrogen-Ion Concentration; Immune Sera; Isoantibodies; Platinum; Purpura, Thrombocytopenic; Quinine; Rabbits; Sheep; Splenectomy; Thrombocytopenia | 1974 |
Preliminary clinical experience with cis-diamminedichloroplatinum (II) (NSC 119875, CACP).
Topics: Amines; Anemia; Antineoplastic Agents; Audiometry; Blood Urea Nitrogen; Bone Marrow; Bone Marrow Cells; Chlorides; Dose-Response Relationship, Drug; Hearing Disorders; Humans; Kidney; Leukopenia; Neoplasm Metastasis; Neoplasms; Platinum; Thrombocytopenia; Time Factors; Uric Acid; Vomiting | 1972 |